UM

Browse/Search Results:  1-5 of 5 Help

Filters                    
Selected(0)Clear Items/Page:    Sort:
Development of pyruvate dehydrogenase kinase inhibitors in medicinal chemistry with particular emphasis as anticancer agents Journal article
Drug Discovery Today, 2015,Volume: 20,Issue: 9,Page: 1112-1119
Authors:  Shao-Lin Zhang;  Xiaohui Hu;  Wen Zhang;  Huankai Yao;  Kin Yip Tam
Favorite  |  View/Download:2/0  |  Submit date:2019/01/07
The prognostic significance of protein tyrosine phosphatase 4A2 in breast cancer Journal article
OncoTargets and Therapy, 2015,Volume: 8,Page: 1707-1717
Authors:  Zhao D.;  Guo L.;  Neves H.;  Yuen H.-F.;  Zhang S.-D.;  McCrudden C.M.;  Wen Q.;  Zhang J.;  Zeng Q.;  Kwok H.F.;  Lin Y.
Favorite  |  View/Download:5/0  |  Submit date:2018/12/19
Breast Cancer  Minichromosome Maintenance Proteins  Overexpression  Prognostic Marker  Ptp4a2  Survival  
The significance of combining VEGFA, FLT1, and KDR expressions in colon cancer patient prognosis and predicting response to bevacizumab Journal article
OncoTargets and Therapy, 2015,Volume: 8,Page: 835-843
Authors:  Zhang S.-D.;  McCrudden C.M.;  Meng C.;  Lin Y.;  Kwok H.F.
Favorite  |  View/Download:8/0  |  Submit date:2018/12/19
Angiogenesis  Colon Cancer  Flt1  Kdr  Survival  Vegfa  
Targeting tumor metabolism for cancer treatment: Is pyruvate dehydrogenase kinases (PDKs) a viable anticancer target? Journal article
International Journal of Biological Sciences, 2015,Volume: 11,Issue: 12,Page: 1390-1400
Authors:  Wen Zhang;  Shao-Lin Zhang;  Xiaohui Hu;  Kin Yip Tam
Favorite  |  View/Download:2/0  |  Submit date:2019/01/07
Aerobic Glycolysis  Pyruvate Dehydrogenase Kinases  Tumor Metabolism  Pyruvate Dehydrogenase Complex  
The prognostic significance of PD-L1 in bladder cancer Journal article
Oncology Reports, 2015,Volume: 33,Issue: 6,Page: 3075
Authors:  Huang Y.;  Zhang S.-D.;  McCrudden C.;  Chan K.-W.;  Lin Y.;  Kwok H.-F.
Favorite  |  View/Download:4/0  |  Submit date:2018/10/30
Bladder Cancer  Patient Survival  Prognostic Marker  Programmed Death Ligand-1  Therapeutic Targets